|
Parsippany, NJ – April 2010 –
HRA Research has announced the introduction of a new
syndicated study on the nursing
home market that will
report on the major changes that are taking
place in this market segment that will affect decisionmaking for
the pharmaceutical industry – including changes in procurement by
nursing home pharmacies, reimbursement through Medicare Part D and
prescribing by physicians. This report will provide a detailed
perspective on the nursing home market and changes taking place that
could have implications in marketing efforts. The report will
discuss the impact of large nursing home pharmacy contracts
involving discounts and rebates,
the
impact of prior
authorization requirements,
and will look at the competitive
landscape of importance to pharmaceutical marketers as the nursing
home market continues to grow during the next five years due to
favorable demographics in the aging population.
The report is based on
qualitative research with nursing home physicians, consultant pharmacists,
nurses, purchasing managers of chains and quantitative research with nursing
home physicians and medical directors and will be published and ready for
distribution in July 2010. “The Nursing Home Market Study will help
pharmaceutical marketers understand sales drivers such as purchasing
requirements among nursing home pharmacists and reimbursement of vaccines and
pharmaceuticals through Medicare Part B and D, and other mechanisms,” said Dilip
Phadnis, HRA Director of New Product Development.
For further
information contact Jack Lepping at
jlepping@hraresearch.com
or 973-240-1190 to purchase the study
HRA Research is a leading market research company that specializes
in the pharmaceutical, biotechnology and medical device industries.
Our complete portfolio of syndicated products and custom research
services provides our clients with actionable intelligence from the
office and hospital setting. HRA utilizes both quantitative and
qualitative research tactics to gather data on healthcare products
at every stage of their lifecycle. For additional information
on syndicated studies, please contact Jack Lepping at
jlepping@hraresearch.com
or 973-240-1190.
<More - What's New> | 
